Introduction: The current epidemiological data and meta-analyses indicate a bidirectional association between depression and metabolic syndrome (MetS).

Aims: To assess the prevalence of metabolic syndrome and obesity in drug naïve patients (in current episode) having Recurrent Major Depressive Disorder and Bipolar Depression.

Method: This was a single point cross sectional observational study that involved administration of diagnostic and assessment tools and blood investigations. Recruitment for the study was done from a period of august 2017 to July 2018.

Results: The prevalence of MetS was significantly more in the depression group when compared to healthy controls. The Bipolar depression group had 24% prevalence and recurrent depression group had 26% prevalence as opposed to none in the control group. The prevalence of MetS did not differ significantly amongst the both depression groups. Presence of central obesity was significantly more in the recurrent depression (30%) and Bipolar depression (24%) as compared to controls (8%). There was no statistically significant difference between the two depression subgroups.

Conclusions: This study demonstrated significantly more incidence of metabolic syndrome and central obesity in patients of depression than age and sex matched controls.

Keywords: Central obesity, depression, metabolic syndrome, obesity

1. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJJ Am CollCardiol. 2010 Sep 28; 56(14):1113-32.[PubMed] [Ref list]
2. Marazziti D, Rutigliano G, Baroni S, Landi P, Dell’Osso L. Metabolic syndrome and major depression. CNS Spectr. 2014; 19:293–304. [PubMed] [Google Scholar]
3. Luppino FS, Bouvy PF, Giltay EJ, Penninx BW, Zitman FG. The metabolic syndrome and related characteristics in major depression: Inpatients and outpatients compared: Metabolic differences across treatment settings. Gen Hosp Psychiatry. 2014;36:509–15. [PubMed] [Google Scholar]
4. van Reedt Dortland AK, Giltay EJ, van Veen T, Zitman FG, Penninx BW. Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepr-essant use. ActaPsychiatr Scand. 2010; 122:30-9. [PubMed] [Google Scholar]
5. Marazziti D, Rutigliano G, Baroni S, Landi P, Dell’Osso L. Metabolic syndrome and major depression. CNS Spectr. 2014;19:293–304. [PubMed] [Google Scholar]
6. Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP. Depression and the metabolic syndrome in young adults: Findings from the Third National Health and Nutrition Examination Survey. Psychosom Med. 2004;66:316–22. [PubMed] [Google Scholar]
7. García-Toro M, Vicens-Pons E, Gili M, Roca M, Serrano-Ripoll MJ, Vives M, et al. Obesity, metabolic syndrome and Mediterranean diet: Impact on depression outcome. J Affect Disord. 2016;194:105–8. [PubMed] [Google Scholar]
8. Depression and cardiovascular disease: Epidemiological evidence on their linking mechanisms. Penninx BW Neurosci Biobehav 2017 Mar; 74(Pt B):277-286. [PubMed] [Ref list]
9. Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant users. Vogelzangs N, Beekman AT, van Reedt Dortland AK, Schoevers RA, Giltay EJ, de Jonge P, Penninx BW Neuropsychopharmacology. 2014 Jun; 39(7):1624-34.[PubMed] [Ref list]
10. Metabolicdys regulation and late-life depression: a prospective study. Marijnissen RM, Vogelzangs N, Mulder ME, van den Brink RH, Comijs HC, Oude Voshaar RCPsychol Med. 2017 Apr; 47(6):1041-1052.[PubMed] [Ref list]
11. Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use.van Reedt Dortland AK, Giltay EJ, van Veen T, Zitman FG, Penninx BW .Acta Psychiatr Scand. 2010 Jul; 122(1):30-9.[PubMed] [Ref list]
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) 2001; 285:2486–97. [PubMed] [Google Scholar]
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition: DSM-IV-TR ®.Washington, DC: American Psychiatric Association; 2000. [Google Scholar]
14. Hamilton M. A rating scale for depression. J NeurolNeurosurg Psychiatry. 1960;23:56–62. [PMC free article] [PubMed] [Google Scholar]
15. Guy W, editor. ECDEU assessment manual for psychopharmacology. Rockville: US Department of Health, Education, and Welfare; 1976. [Google Scholar]
16. American Psychiatric Association. Global assessment of functioning scale. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000. p. 34. [Google Scholar]
17. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Jr, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. J Am Coll Cardiol. 2004; 44:720–32. [PubMed] [Google Scholar].

Dr Raginee Singh

P. G. Resident, Katihar Medical College and Hospital, Katihar [Bihar], India